1. Home
  2. KMDA vs BKSY Comparison

KMDA vs BKSY Comparison

Compare KMDA & BKSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KMDA
  • BKSY
  • Stock Information
  • Founded
  • KMDA 1990
  • BKSY 2013
  • Country
  • KMDA Israel
  • BKSY United States
  • Employees
  • KMDA N/A
  • BKSY N/A
  • Industry
  • KMDA Biotechnology: Pharmaceutical Preparations
  • BKSY Radio And Television Broadcasting And Communications Equipment
  • Sector
  • KMDA Health Care
  • BKSY Technology
  • Exchange
  • KMDA Nasdaq
  • BKSY Nasdaq
  • Market Cap
  • KMDA 349.6M
  • BKSY 328.4M
  • IPO Year
  • KMDA N/A
  • BKSY N/A
  • Fundamental
  • Price
  • KMDA $7.16
  • BKSY $11.71
  • Analyst Decision
  • KMDA Strong Buy
  • BKSY Strong Buy
  • Analyst Count
  • KMDA 2
  • BKSY 5
  • Target Price
  • KMDA $14.50
  • BKSY $17.60
  • AVG Volume (30 Days)
  • KMDA 142.0K
  • BKSY 1.0M
  • Earning Date
  • KMDA 03-05-2025
  • BKSY 02-26-2025
  • Dividend Yield
  • KMDA N/A
  • BKSY N/A
  • EPS Growth
  • KMDA 124.29
  • BKSY N/A
  • EPS
  • KMDA 0.27
  • BKSY N/A
  • Revenue
  • KMDA $158,380,000.00
  • BKSY $107,231,000.00
  • Revenue This Year
  • KMDA $15.81
  • BKSY $14.37
  • Revenue Next Year
  • KMDA $5.79
  • BKSY $25.81
  • P/E Ratio
  • KMDA $26.36
  • BKSY N/A
  • Revenue Growth
  • KMDA 4.52
  • BKSY 36.77
  • 52 Week Low
  • KMDA $4.74
  • BKSY $3.86
  • 52 Week High
  • KMDA $8.00
  • BKSY $14.16
  • Technical
  • Relative Strength Index (RSI)
  • KMDA 70.04
  • BKSY 58.87
  • Support Level
  • KMDA $7.00
  • BKSY $9.81
  • Resistance Level
  • KMDA $8.00
  • BKSY $12.64
  • Average True Range (ATR)
  • KMDA 0.31
  • BKSY 0.91
  • MACD
  • KMDA 0.06
  • BKSY -0.07
  • Stochastic Oscillator
  • KMDA 60.93
  • BKSY 72.07

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

About BKSY BlackSky Technology Inc.

BlackSky Technology Inc is a provider of real-time geospatial intelligence. The company delivers on-demand, high-frequency imagery, monitoring, and analytics of some of the critical and strategic locations, economic assets, and events in the world. It designs, owns, and operates one of the industry's low earth orbit (LEO) small satellite constellations, optimized to capture imagery cost-efficiently where and when its customers need it. its Spectra AI software platform processes data from BlackSky's constellation and from other third-party sensors to develop the critical insights and analytics that provide its customers with the actionable intelligence. Geographically, the company operates in North America, the Middle East, Asia, and Others.

Share on Social Networks: